2.45
price down icon1.21%   -0.03
after-market Handel nachbörslich: 2.46 0.010 +0.41%
loading
Schlusskurs vom Vortag:
$2.48
Offen:
$2.49
24-Stunden-Volumen:
125.44K
Relative Volume:
0.30
Marktkapitalisierung:
$42.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.61%
1M Leistung:
+0.00%
6M Leistung:
-37.97%
1J Leistung:
-27.73%
1-Tages-Spanne:
Value
$2.45
$2.5237
1-Wochen-Bereich:
Value
$2.45
$2.54
52-Wochen-Spanne:
Value
$0.95
$4.74

Mural Oncology Plc Stock (MURA) Company Profile

Name
Firmenname
Mural Oncology Plc
Name
Telefon
353 1 905 8020
Name
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Name
Mitarbeiter
116
Name
Twitter
Name
Nächster Verdiensttermin
2025-05-20
Name
Neueste SEC-Einreichungen
Name
MURA's Discussions on Twitter

Vergleichen Sie MURA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MURA
Mural Oncology Plc
2.45 43.00M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Mural Oncology Plc Stock (MURA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-25 Herabstufung Morgan Stanley Overweight → Equal-Weight
2025-03-25 Herabstufung Raymond James Strong Buy → Outperform
2024-06-28 Eingeleitet Rodman & Renshaw Buy
2024-04-04 Eingeleitet Morgan Stanley Overweight

Mural Oncology Plc Aktie (MURA) Neueste Nachrichten

pulisher
Jul 22, 2025

Mural Oncology plc Stock Analysis and ForecastGame-changing capital returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Mural Oncology plc stock priceHigh-yield investments - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Form 8.3Mural Oncology plc - Business Wire

Jul 22, 2025
pulisher
Jul 22, 2025

Why Mural Oncology plc stock attracts strong analyst attentionReturn Maximized Portfolio Strategy - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Mural Oncology plc stockExceptional market positioning - printweek.in

Jul 22, 2025
pulisher
Jul 22, 2025

Is Mural Oncology plc a good long term investmentRapid-fire capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Can Mural Oncology (NASDAQ:MURA) Afford To Invest In Growth? - Yahoo Finance

Jul 21, 2025
pulisher
Jul 15, 2025

How Mural Oncology plc stock performs during market volatilityFree Investment Risk Control - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Mural Oncology plc stock price move sharplyFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Geode Capital discloses 1.01% stake in Mural Oncology By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Geode Capital discloses 1.01% stake in Mural Oncology - Investing.com

Jul 15, 2025
pulisher
Jul 14, 2025

Concurrent Investment Advisors LLC Makes New $28,000 Investment in Mural Oncology PLC (NASDAQ:MURA) - Defense World

Jul 14, 2025
pulisher
Jul 11, 2025

BlackRock discloses 1.65% stake in Mural Oncology - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

BlackRock discloses 1.65% stake in Mural Oncology By Investing.com - Investing.com Nigeria

Jul 11, 2025
pulisher
Jul 08, 2025

The Vanguard Group, Inc. Discloses Interest in Mural Oncology plc - AInvest

Jul 08, 2025
pulisher
Jul 05, 2025

Mural Oncology (NASDAQ:MURA) Trading 3.2% Higher – Should You Buy? - Defense World

Jul 05, 2025
pulisher
Jul 02, 2025

Cancer index outperforms broader markets with 13% Q2 rebound - BioWorld MedTech

Jul 02, 2025
pulisher
Jun 27, 2025

LMR Partners discloses 2.99% stake in Mural Oncology By Investing.com - Investing.com South Africa

Jun 27, 2025
pulisher
Jun 27, 2025

LMR Partners discloses 2.99% stake in Mural Oncology - Investing.com

Jun 27, 2025
pulisher
Jun 26, 2025

Alkermes spinoff Mural plunges on plans to halt ovarian cancer trial - MSN

Jun 26, 2025

Finanzdaten der Mural Oncology Plc-Aktie (MURA)

Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):